Cost effectiveness of routine type and screen testing before laparoscopic cholecystectomy

In modern surgical practice, the need for routine preoperative testing is often debated. Blood type and screen tests are frequently ordered before surgeries, but their necessity is not always clear. Prior research has shown that laparoscopic cholecystectomy is a safe and effective procedure. However, the frequency of blood transfusions remains a concern. Open cholecystectomy has historically been associated with higher transfusion rates. This gap motivated the need to evaluate whether routine blood type and screen testing is cost-effective for laparoscopic cholecystectomy. The absence of clear evidence on this topic has left a gap in clinical decision-making. No prior work had resolved the economic impact of eliminating this test. Understanding transfusion risks and their relation to surgical technique is essential for optimizing care. This study aimed to provide clarity on the financial and clinical implications of routine testing.

The study aimed to evaluate the cost-effectiveness of routine preoperative blood type and screen testing for laparoscopic cholecystectomy. Laparoscopic cholecystectomy is a common surgical procedure, but its transfusion requirements are low. The researchers wanted to determine if eliminating this test would reduce healthcare costs without compromising patient safety. The motivation came from the growing emphasis on cost containment in managed healthcare. The study focused on comparing transfusion rates between laparoscopic and open cholecystectomy. The researchers sought to identify the causes of transfusions in both groups. By analyzing historical data, they aimed to assess the necessity of routine testing. The study also aimed to quantify the financial impact of eliminating the test.

The researchers conducted a retrospective review of surgical records from 1990 to 1996. They analyzed 2,589 laparoscopic and 603 open cholecystectomies performed at their institution. ICD-9-CM coding was used to identify cases involving blood transfusions. Computerized data extraction matched surgical codes with transfusion records. Individual patient charts were reviewed to determine transfusion reasons. The study compared transfusion rates between the two surgical approaches. Researchers calculated the incidence of transfusions in each group. They also estimated the potential cost savings from eliminating routine testing.

The transfusion rate for laparoscopic cholecystectomy was 0.46%, with 12 patients requiring blood. For open cholecystectomy, the rate was 5.47%, with 33 patients needing transfusions. Two transfusions in the laparoscopic group were due to major vascular injury. The remaining transfusions were linked to preexisting conditions like sickle-cell anemia. No routine transfusions were given in the absence of clinical indications. The study found no significant complications from not having blood available. The researchers estimated a potential cost saving of $79,800 over six years. These findings suggest that routine testing may not be necessary for most patients.

The authors concluded that routine preoperative blood type and screen testing may not be necessary for laparoscopic cholecystectomy. The low transfusion rate in this group suggests that the test may not add clinical value. The study supports the idea that eliminating this test could reduce healthcare costs. The researchers proposed that preoperative testing should be based on clinical need rather than routine practice. The findings may help guide decisions in managed healthcare settings. The study did not find evidence to support the necessity of this test. The authors suggested that cost savings could be achieved without compromising patient safety. Their results may inform future guidelines on preoperative testing.